Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22642,178,1.01 [0.87-1.17],0.9267232712674583
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23671,192,1.06 [0.91-1.22],0.462146510417067
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23428,1406,1.04 [0.99-1.10],0.1307199158240067
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23686,375,1.04 [0.94-1.15],0.4629605054721609
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22997,3466,1.03 [1.00-1.07],0.084332665302021
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22957,3486,1.00 [0.97-1.04],0.8786099782004317
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23468,1044,1.01 [0.95-1.08],0.733875319463742
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23605,81,0.94 [0.75-1.17],0.5672878504999339
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21472,1119,1.02 [0.96-1.08],0.4822942311835141
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20714,1238,1.01 [0.96-1.07],0.6480610228640187
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20441,252,1.06 [0.94-1.21],0.3340147374167233
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16644,2266,0.99 [0.95-1.04],0.7835236712316005
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20364,402,1.08 [0.98-1.19],0.1367859212253724
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23675,1251,1.02 [0.96-1.08],0.5512764884406647
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,23777,466,1.02 [0.93-1.12],0.6295875658247072
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22916,894,1.03 [0.97-1.10],0.3457955618724415
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23700,1236,1.02 [0.96-1.08],0.536623825987129
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22618,194,1.04 [0.90-1.20],0.5604343754074115
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23816,51,1.31 [0.99-1.73],0.059020504087169
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23542,1078,1.01 [0.95-1.08],0.6758322672254216
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23597,73,1.22 [0.97-1.54],0.0954740004063441
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23756,124,1.19 [0.99-1.42],0.058733371124167
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23735,103,1.26 [1.04-1.54],0.0196142963793691
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22507,485,1.14 [1.04-1.25],0.0049879641078492
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22307,285,1.00 [0.89-1.13],0.9841560305969944
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22513,89,1.00 [0.81-1.23],0.9937560479323851
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23797,70,0.86 [0.67-1.08],0.1968750388312642
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23760,143,1.07 [0.90-1.26],0.4468061605877936
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,23668,51,1.20 [0.91-1.59],0.2013027024680901
PLA2G4A,Cytosolic phospholipase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23668,51,0.90 [0.68-1.20],0.484113663412301
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,23499,340,0.96 [0.86-1.07],0.4407486489223837
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23745,45,1.02 [0.76-1.37],0.9041987417536222
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23711,52,1.02 [0.77-1.34],0.8888791861636657
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23767,129,0.94 [0.79-1.12],0.4666114367238445
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23441,1643,1.01 [0.97-1.07],0.5562479918337924
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign neoplasm of meninges,23816,33,1.10 [0.78-1.55],0.6014765675145448
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23752,65,0.87 [0.68-1.12],0.2903730776569767
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23801,78,0.99 [0.79-1.25],0.9644116584265184
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23791,440,1.01 [0.92-1.11],0.853626512453036
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,23786,340,1.01 [0.90-1.12],0.8927536795543317
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23686,81,0.94 [0.75-1.17],0.570248566368033
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23783,277,1.04 [0.92-1.17],0.5580527200185914
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,23743,419,0.95 [0.87-1.05],0.34125521022339
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23691,733,1.04 [0.96-1.12],0.3245030858750442
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23773,562,1.05 [0.97-1.15],0.2183960630015966
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18492,70,0.95 [0.75-1.21],0.7064705041288393
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18493,71,0.92 [0.72-1.16],0.4798965328627163
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23785,101,1.01 [0.83-1.23],0.9180031484593868
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",23785,99,1.00 [0.82-1.23],0.9652925811814692
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,15844,340,1.08 [0.97-1.20],0.168976829714629
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Lymphoid leukaemia,18487,65,0.92 [0.71-1.18],0.490305382494221
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18620,198,1.06 [0.92-1.22],0.4497095814078453
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18710,288,1.03 [0.92-1.16],0.6081378032857734
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18517,95,0.89 [0.72-1.09],0.2510017983364956
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18567,145,1.05 [0.89-1.24],0.5836425270459009
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18561,139,1.01 [0.86-1.20],0.8684798964568192
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18505,83,1.05 [0.84-1.31],0.6492128355631064
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19824,1402,0.97 [0.92-1.03],0.3424365413167128
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18565,143,0.96 [0.81-1.13],0.6063622107631216
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18528,106,1.21 [0.99-1.46],0.0591890199652903
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18552,130,0.98 [0.83-1.17],0.8628824859059498
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,23687,170,0.93 [0.79-1.08],0.3251332933082062
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,23783,95,1.05 [0.85-1.28],0.6691219464517466
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Melanoma in situ,18455,74,1.18 [0.94-1.49],0.160862483336861
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18522,100,0.95 [0.78-1.16],0.6338258975595732
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18589,167,0.96 [0.82-1.12],0.6236068974460305
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18636,214,1.05 [0.92-1.21],0.4620527826905687
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18524,102,0.94 [0.77-1.15],0.5394109268602865
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,23682,140,1.02 [0.86-1.20],0.8481233011800512
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19630,1208,0.98 [0.93-1.04],0.5051190062239517
PLA2G4A,Cytosolic phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19708,1286,0.99 [0.94-1.05],0.7701196453846534
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23539,309,1.01 [0.90-1.14],0.810853001510097
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22082,118,1.01 [0.84-1.21],0.9312858041593496
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23303,73,0.99 [0.78-1.25],0.9389712238424264
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23253,2785,1.01 [0.97-1.05],0.5576818182230965
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22531,60,1.37 [1.06-1.77],0.0160317541890467
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23390,53,0.75 [0.57-0.99],0.0452922010512142
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23436,1472,1.04 [0.99-1.09],0.1559714871440533
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23434,1470,1.04 [0.98-1.09],0.1702052706428248
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22068,104,0.94 [0.77-1.14],0.5377123160020758
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23577,1106,1.05 [0.99-1.12],0.1115655416799396
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23442,105,1.01 [0.83-1.23],0.934653991668667
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23306,76,0.91 [0.73-1.15],0.4449809544312473
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23291,61,1.13 [0.87-1.45],0.3617198758749015
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23651,314,0.75 [0.67-0.84],7.466489795054696e-07
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23718,49,0.88 [0.66-1.17],0.3691468688950867
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23594,257,0.70 [0.62-0.80],4.786092859504937e-08
PLA2G4A,Cytosolic phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22550,79,0.87 [0.69-1.09],0.2233036786435705
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17553,375,0.98 [0.89-1.09],0.7441133561792934
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21773,163,1.13 [0.97-1.32],0.11607545024862
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21800,190,1.07 [0.92-1.23],0.3827198918176371
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17232,54,1.08 [0.83-1.42],0.5550063692908506
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22440,64,0.84 [0.66-1.08],0.1845680870228622
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21671,225,0.97 [0.85-1.10],0.6152686999688952
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23312,617,1.01 [0.93-1.09],0.8861979910129624
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22936,241,0.92 [0.81-1.05],0.2269022059038004
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22865,170,1.13 [0.97-1.32],0.1245967447188666
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23514,1138,1.08 [1.02-1.14],0.0118964374976501
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20371,1094,1.07 [1.01-1.14],0.0254596189641481
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17253,75,0.80 [0.63-1.01],0.0586798286743094
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22944,39,1.07 [0.78-1.47],0.6770921614830212
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17450,272,1.08 [0.95-1.21],0.2358709232549897
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17254,76,1.12 [0.89-1.41],0.3277132944800416
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21058,3880,1.05 [1.02-1.08],0.0040203480294818
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17363,185,1.01 [0.87-1.17],0.8970972437635764
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17746,568,1.05 [0.96-1.14],0.2830266103488071
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23757,277,0.99 [0.88-1.11],0.8307684736760417
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23571,91,0.77 [0.62-0.95],0.0129157499834791
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17329,151,1.08 [0.92-1.27],0.3650469683817738
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17244,66,1.03 [0.81-1.32],0.7938549972650736
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23640,735,1.02 [0.95-1.10],0.5412592426023898
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17485,307,1.06 [0.94-1.19],0.3245247064037511
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17559,381,0.83 [0.75-0.92],0.0005281765124083
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17906,728,1.07 [0.99-1.15],0.0926657174479319
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17322,144,0.87 [0.73-1.03],0.1038294250662272
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23564,84,0.77 [0.62-0.96],0.0188036055988423
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17751,573,1.10 [1.01-1.19],0.0274546085671344
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17566,388,1.02 [0.92-1.13],0.6691590287238772
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21514,68,0.99 [0.78-1.26],0.9440092426902874
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22378,5200,1.03 [1.00-1.06],0.0295799165774426
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22925,20,0.94 [0.60-1.47],0.79673384735329
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22926,21,1.10 [0.72-1.70],0.6604547337282254
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23643,1778,0.96 [0.92-1.01],0.1232895490991212
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23640,1774,0.96 [0.92-1.01],0.1390924440361715
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22928,23,1.86 [1.24-2.80],0.0029565692604696
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23543,802,1.03 [0.96-1.11],0.4009672924233376
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18799,1621,1.00 [0.95-1.05],0.9353445155268588
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23805,265,0.99 [0.87-1.12],0.8220941856159132
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22802,107,1.02 [0.84-1.24],0.8046286721413278
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22817,76,1.02 [0.81-1.28],0.8668254867707004
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22823,82,1.24 [0.99-1.54],0.0576795753825483
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17243,65,1.14 [0.89-1.46],0.3092867850861979
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21025,168,1.01 [0.86-1.18],0.9223729908647528
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2510,121,1.03 [0.86-1.23],0.7647980832994452
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2674,318,0.95 [0.85-1.06],0.3769739462776189
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20956,99,1.07 [0.88-1.30],0.505246316090832
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2468,81,0.92 [0.73-1.15],0.465408114666999
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23025,2168,1.04 [1.00-1.09],0.0681722313382463
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23057,362,0.90 [0.81-1.00],0.0532350022298988
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21687,241,0.98 [0.86-1.11],0.7446774045789043
PLA2G4A,Cytosolic phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17978,800,1.04 [0.96-1.11],0.3375499244044746
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23691,253,0.96 [0.85-1.09],0.5077405056067015
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22582,271,0.91 [0.81-1.03],0.1309517092422251
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,20896,1488,0.96 [0.92-1.02],0.1736683624181932
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22692,381,0.94 [0.85-1.04],0.2331359573446399
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22395,84,1.09 [0.88-1.35],0.433777957101871
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22561,250,1.10 [0.97-1.24],0.1546282445072378
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13948,2315,0.97 [0.93-1.01],0.1570537786771548
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,AV-block,19154,623,1.01 [0.93-1.09],0.8909312347062901
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23740,533,0.97 [0.89-1.06],0.5621171189686311
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,11882,249,1.07 [0.94-1.21],0.3179423493103984
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18734,203,0.89 [0.77-1.03],0.1081365475062186
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18643,112,0.88 [0.73-1.07],0.1985526484477056
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23817,68,1.12 [0.87-1.42],0.377830101766387
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,19901,1370,0.99 [0.94-1.05],0.829318939493085
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22005,2621,1.02 [0.98-1.06],0.3421438245361486
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20059,7761,1.02 [1.00-1.05],0.0368060849450743
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22581,277,0.94 [0.83-1.06],0.2994034416976356
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Endocarditis,18614,83,0.98 [0.79-1.23],0.8792638015278351
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23507,1330,1.02 [0.96-1.07],0.561437481663276
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,21259,6765,1.04 [1.01-1.06],0.0043417629224061
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21282,6788,1.03 [1.01-1.06],0.005976111154063
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23584,113,0.92 [0.76-1.11],0.3707502549302827
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14677,183,1.02 [0.88-1.19],0.7625453315160494
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14663,169,1.00 [0.86-1.16],0.9695220331546848
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,23669,1239,1.07 [1.01-1.14],0.0150617176331701
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22747,119,0.87 [0.72-1.04],0.1277744136589345
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22149,2741,1.01 [0.97-1.05],0.5473840787939512
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23386,652,1.10 [1.02-1.19],0.0169868346793173
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18952,421,1.01 [0.92-1.11],0.8460551126544558
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23090,1060,1.02 [0.96-1.09],0.5101220830541688
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20328,920,1.03 [0.97-1.10],0.3496714513446092
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23654,221,1.09 [0.96-1.25],0.1968442118777278
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23765,371,0.98 [0.88-1.08],0.6725565772539948
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22376,72,0.90 [0.71-1.14],0.3885094715467968
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,22409,98,0.99 [0.81-1.22],0.9560823851760027
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,19012,481,1.03 [0.94-1.13],0.5207207001283807
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22446,135,1.04 [0.87-1.23],0.6771449470686556
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22597,286,0.94 [0.84-1.06],0.343905145116644
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18722,191,1.05 [0.91-1.22],0.4755701147699273
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22402,98,1.02 [0.83-1.25],0.8515767938959662
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22354,50,1.17 [0.88-1.55],0.2762271466551252
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22223,88,1.05 [0.85-1.30],0.6601911760365251
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22411,107,0.97 [0.80-1.17],0.7270906333793636
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19780,1249,0.98 [0.93-1.04],0.561196286671865
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22496,66,0.93 [0.72-1.18],0.5430018115580086
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22883,572,1.08 [0.99-1.17],0.071306659521835
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23175,366,1.06 [0.96-1.18],0.2546138671891735
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22802,667,1.06 [0.98-1.14],0.1480648198433486
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,12014,381,0.92 [0.83-1.02],0.1075058729896543
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22795,530,1.05 [0.96-1.14],0.278556889330483
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22660,356,0.95 [0.86-1.06],0.3646688469969189
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23302,493,0.97 [0.89-1.07],0.5757085828445831
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23756,715,1.02 [0.94-1.10],0.6623031577753951
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,19004,473,0.98 [0.89-1.07],0.6470968799827116
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23173,364,1.06 [0.95-1.18],0.2742711289127163
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22360,225,1.08 [0.95-1.23],0.2528881477670277
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23370,742,1.07 [1.00-1.16],0.0559516141736402
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23354,772,1.07 [1.00-1.15],0.0622912794617932
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22724,48,0.92 [0.69-1.23],0.5938996691391635
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22426,116,0.89 [0.74-1.08],0.2372532582050898
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22986,252,1.01 [0.89-1.15],0.8486208736619091
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22344,314,1.01 [0.91-1.13],0.8182077983395581
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,22687,383,0.96 [0.87-1.06],0.4500228583683916
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22330,73,0.90 [0.71-1.14],0.38924914505053
PLA2G4A,Cytosolic phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23577,778,0.96 [0.90-1.03],0.3018615066983734
PLA2G4A,Cytosolic phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23619,497,1.05 [0.96-1.15],0.2538700138098432
PLA2G4A,Cytosolic phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20472,973,1.06 [0.99-1.13],0.0798320972025458
PLA2G4A,Cytosolic phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,23128,3629,1.03 [0.99-1.06],0.1367525813489077
PLA2G4A,Cytosolic phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23556,585,1.06 [0.98-1.15],0.1470839904250438
PLA2G4A,Cytosolic phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20672,1173,1.06 [1.00-1.12],0.050307977305352
PLA2G4A,Cytosolic phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19584,85,1.04 [0.84-1.28],0.7469242094941477
PLA2G4A,Cytosolic phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,23166,1533,1.01 [0.97-1.07],0.5786146242340123
PLA2G4A,Cytosolic phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21367,1868,1.03 [0.99-1.08],0.1950076542287731
PLA2G4A,Cytosolic phospholipase A2,Chapter V Mental and behavioural disorders,Vascular dementia,23304,150,0.89 [0.75-1.04],0.1483669372615866
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,23815,298,0.95 [0.85-1.07],0.433394751081545
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15822,58,0.95 [0.73-1.24],0.693182026481431
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Bell's palsy,22448,75,1.06 [0.84-1.33],0.6364844605243353
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22712,339,1.07 [0.96-1.20],0.2031203825808302
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,23409,239,1.02 [0.90-1.16],0.7807322784987416
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23731,366,1.01 [0.91-1.13],0.7924858910990094
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23308,60,1.09 [0.84-1.41],0.5112323417230851
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23797,73,0.82 [0.65-1.03],0.0921558314198187
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23262,92,1.03 [0.83-1.26],0.7998828407685376
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,22198,288,0.97 [0.86-1.09],0.5915305285202439
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23279,1369,1.03 [0.98-1.09],0.2520700927618182
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23780,681,1.00 [0.92-1.07],0.902075980290128
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23270,2211,0.99 [0.95-1.03],0.5984942234167138
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23424,59,1.13 [0.87-1.46],0.3524102285665176
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,23647,282,1.03 [0.92-1.16],0.5965564972944575
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,23226,56,1.00 [0.77-1.30],0.9991298720591132
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23798,58,1.33 [1.02-1.72],0.0330573696332462
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22393,20,0.78 [0.50-1.22],0.2777947453662852
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22469,96,1.00 [0.82-1.23],0.9916366852015642
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Memory loss,23145,119,0.88 [0.73-1.06],0.1722873870245285
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,22106,196,1.06 [0.92-1.22],0.4171699216078033
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23792,177,1.08 [0.93-1.25],0.3277914897901126
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,15929,152,1.10 [0.93-1.29],0.253177622013073
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23705,64,0.95 [0.74-1.22],0.6844619571437268
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23348,975,1.04 [0.98-1.11],0.2001932089104787
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,22503,3678,1.02 [0.99-1.05],0.2488884514610306
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23487,239,1.06 [0.93-1.21],0.3468760886998707
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22764,391,1.06 [0.96-1.17],0.2684492686680008
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23722,349,1.04 [0.93-1.16],0.466714935175295
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18670,621,1.02 [0.95-1.11],0.5486382182484311
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23250,80,0.87 [0.69-1.09],0.2189288779005561
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23325,155,0.96 [0.82-1.13],0.6433550894084199
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23235,136,0.96 [0.81-1.14],0.6243702041365478
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22467,94,1.02 [0.83-1.25],0.8546688329576567
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,21947,37,0.96 [0.69-1.33],0.8032028592763731
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,23697,527,1.01 [0.92-1.10],0.9099341640664312
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,22615,705,1.06 [0.99-1.15],0.1104058954014113
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,23794,536,1.01 [0.93-1.10],0.7880028048050715
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23198,28,0.95 [0.65-1.38],0.7824485577969608
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23816,46,1.03 [0.77-1.38],0.8462500104555254
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,23512,634,1.06 [0.98-1.15],0.1279338369539168
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23431,58,1.00 [0.76-1.30],0.9741169020158418
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23798,178,1.12 [0.97-1.30],0.1328463471789325
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22408,35,1.02 [0.73-1.43],0.905308117283442
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23815,301,0.95 [0.85-1.07],0.4266032750341115
PLA2G4A,Cytosolic phospholipase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23273,146,0.88 [0.75-1.05],0.1516105590785729
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23265,88,1.17 [0.95-1.45],0.1494552621269397
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23472,300,0.96 [0.86-1.08],0.5373635092203608
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23616,292,0.95 [0.84-1.07],0.382035096229167
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22943,44,0.89 [0.66-1.21],0.4496057823196568
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22958,59,1.28 [0.99-1.66],0.0587620207679558
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23726,44,1.12 [0.83-1.52],0.4454287075120765
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23586,124,1.08 [0.90-1.29],0.4265346505458318
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2472,83,0.92 [0.74-1.15],0.4609498211136066
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3008,128,1.07 [0.90-1.27],0.472353955439302
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23268,91,1.40 [1.13-1.72],0.001727888798611
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23568,996,1.00 [0.94-1.06],0.9316385481565532
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23511,612,0.98 [0.90-1.06],0.6078685150727394
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23042,143,1.10 [0.93-1.31],0.2532099720021864
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23741,569,1.01 [0.93-1.10],0.8237698843083029
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23813,63,1.07 [0.83-1.38],0.5946964010791178
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23675,503,0.98 [0.90-1.07],0.6648704339657633
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23776,314,1.06 [0.95-1.19],0.305692236627463
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23725,148,1.10 [0.93-1.30],0.2562209634223237
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22978,79,1.08 [0.86-1.36],0.484983983252213
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22985,86,0.84 [0.68-1.05],0.1239189192555989
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22943,44,1.05 [0.77-1.43],0.7477524804075355
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23720,679,1.01 [0.94-1.10],0.706989376711802
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23224,183,1.04 [0.89-1.20],0.6407393693863668
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23201,29,0.65 [0.45-0.95],0.0256922566081013
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23559,97,1.00 [0.81-1.22],0.9658440662306002
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23685,223,1.06 [0.92-1.21],0.4170361933224484
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23344,172,1.06 [0.91-1.23],0.4880999053995065
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23660,83,1.08 [0.87-1.35],0.4730197346672116
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23500,459,1.07 [0.97-1.17],0.1676177958531955
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23308,131,1.09 [0.91-1.30],0.3438156745995396
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22434,1788,1.05 [1.00-1.10],0.0616879576213381
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23656,194,1.04 [0.90-1.20],0.6058848448576326
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23800,145,1.15 [0.97-1.35],0.104122027399881
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23317,418,0.92 [0.84-1.02],0.1178156610649393
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23528,66,0.94 [0.73-1.20],0.5973973988969566
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23804,54,1.07 [0.81-1.40],0.6494879560575311
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22975,76,0.89 [0.71-1.13],0.3439143399164793
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23037,138,0.91 [0.76-1.07],0.2570892844465639
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22698,126,1.05 [0.88-1.26],0.5693010701297481
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23220,48,1.10 [0.82-1.46],0.5276781886023758
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22635,63,0.89 [0.69-1.14],0.3520537286719447
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23091,50,0.83 [0.63-1.11],0.2036189140435842
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23250,209,1.09 [0.95-1.25],0.2228683126189397
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23017,118,0.93 [0.77-1.12],0.460610706395814
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22694,122,1.22 [1.02-1.46],0.029146993473968
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22664,92,0.95 [0.77-1.17],0.61202413766751
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22121,1475,1.01 [0.96-1.07],0.6789600898229546
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22956,57,1.03 [0.79-1.35],0.8136260604469994
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23568,391,1.18 [1.07-1.30],0.001414758501616
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23248,71,1.16 [0.92-1.46],0.2223808859350119
PLA2G4A,Cytosolic phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23346,169,1.05 [0.90-1.23],0.5038994055996837
PLA2G4A,Cytosolic phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23640,57,0.90 [0.69-1.17],0.4276907819142017
PLA2G4A,Cytosolic phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23773,121,1.14 [0.95-1.36],0.1657826165414569
PLA2G4A,Cytosolic phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23683,111,1.11 [0.92-1.35],0.2601586097602443
PLA2G4A,Cytosolic phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23633,50,1.07 [0.80-1.41],0.6516069995817226
PLA2G4A,Cytosolic phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23636,53,1.06 [0.80-1.39],0.6867530494736956
PLA2G4A,Cytosolic phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23722,965,1.02 [0.96-1.09],0.5589841364005823
PLA2G4A,Cytosolic phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23474,717,1.02 [0.95-1.10],0.5221185008151339
PLA2G4A,Cytosolic phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22888,131,0.87 [0.73-1.04],0.1271776315012789
PLA2G4A,Cytosolic phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22840,83,1.17 [0.94-1.46],0.149557295312834
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23605,63,0.94 [0.73-1.20],0.602815797358287
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23730,188,0.98 [0.85-1.14],0.8088838423777321
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23602,60,0.89 [0.69-1.15],0.3783014667171777
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,All influenza,21520,109,1.09 [0.90-1.32],0.3878744216631774
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21517,106,1.12 [0.93-1.36],0.2362166315956188
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15608,104,1.11 [0.92-1.35],0.2809697692912188
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23707,266,1.05 [0.93-1.19],0.4031694008416497
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16584,1429,1.06 [1.01-1.12],0.0249068295614438
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16908,1404,1.06 [1.01-1.12],0.0306310315190168
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23429,151,1.06 [0.90-1.25],0.4516526421683576
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21506,95,1.09 [0.89-1.33],0.4173053356196848
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,20704,289,1.07 [0.96-1.21],0.2312948767621989
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20458,43,1.47 [1.09-1.99],0.0124102378900329
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22960,2545,1.05 [1.01-1.09],0.0112628029503778
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22370,79,1.22 [0.97-1.52],0.0839448289971186
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22452,161,1.13 [0.97-1.33],0.115647424193229
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23591,1300,1.04 [0.98-1.10],0.1980248061500529
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22431,140,1.04 [0.88-1.23],0.6686990607695398
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21799,5267,1.04 [1.01-1.07],0.0052502431364619
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22683,392,1.06 [0.96-1.17],0.2483132602632134
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,22595,304,1.00 [0.89-1.12],0.9740415186742358
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Emphysema,20762,347,1.11 [1.00-1.23],0.0552684129383174
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22881,335,1.07 [0.96-1.20],0.2102849082231776
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23565,2154,1.04 [1.00-1.09],0.0644992844669913
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22910,364,1.10 [0.99-1.22],0.0718578442151248
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Later onset COPD,22748,996,1.05 [0.99-1.12],0.1276963661533068
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23799,426,1.06 [0.96-1.17],0.2473296739109702
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,22435,144,1.08 [0.92-1.28],0.3351090253112094
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23547,1001,1.07 [1.01-1.14],0.0277772620179225
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23534,2190,1.07 [1.02-1.12],0.0021980833906934
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23162,871,1.06 [0.99-1.13],0.1108021179968399
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,21410,66,0.96 [0.75-1.22],0.7266180601289886
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23720,448,1.08 [0.98-1.19],0.1154845876280388
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23692,1384,1.09 [1.03-1.15],0.0025075239477292
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,22467,1123,1.05 [0.99-1.11],0.1080538026079954
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Pleural plaque,21609,265,1.05 [0.93-1.18],0.4698698637794392
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23301,1890,1.04 [0.99-1.09],0.0834000913229483
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23697,324,1.09 [0.97-1.22],0.13248041638921
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Pneumothorax,21484,140,0.95 [0.81-1.13],0.587857494285182
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Pollen allergy,23800,231,1.11 [0.97-1.26],0.1254611525827716
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23340,68,0.94 [0.74-1.20],0.6210525927065484
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15560,56,1.21 [0.93-1.57],0.1650270894694714
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23529,983,1.07 [1.01-1.15],0.0280452809392057
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22559,268,1.06 [0.94-1.20],0.3445925159459949
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,21692,281,1.02 [0.90-1.15],0.7677072622758454
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23447,238,0.97 [0.85-1.10],0.6516414439162783
PLA2G4A,Cytosolic phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10369,118,0.99 [0.82-1.19],0.8781263991897829
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16615,89,1.05 [0.85-1.29],0.6735669267471192
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,23680,144,1.11 [0.94-1.31],0.2022387454496755
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Acute gastritis,17969,90,1.05 [0.85-1.29],0.6619149327059847
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22457,203,0.96 [0.83-1.10],0.5318711452537156
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,23459,100,1.01 [0.83-1.24],0.8982554920289062
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22917,117,0.89 [0.74-1.06],0.1930763217822627
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18407,528,0.94 [0.86-1.03],0.178906322744979
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22376,122,0.92 [0.77-1.11],0.3915079071056382
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23408,122,0.92 [0.77-1.10],0.3672234862527589
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,22473,219,0.89 [0.78-1.02],0.0964657538703322
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,23043,789,1.01 [0.94-1.08],0.7914415259915017
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,18144,265,0.94 [0.83-1.06],0.295062700509016
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22310,56,1.00 [0.76-1.30],0.9770693227612112
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23607,136,0.87 [0.74-1.04],0.1260597236070985
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,22175,95,1.15 [0.94-1.41],0.1843146445704038
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,22373,48,1.16 [0.87-1.54],0.3192724802302714
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23648,222,0.90 [0.79-1.03],0.1314937802251536
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,23653,1597,1.01 [0.97-1.07],0.5672012169303527
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,22418,93,1.18 [0.96-1.45],0.1120013857518063
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23471,67,1.17 [0.92-1.49],0.2077030422546501
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22403,78,1.24 [0.99-1.55],0.0647689990085889
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,23169,228,1.15 [1.01-1.31],0.0333819607948592
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20173,1948,0.99 [0.95-1.04],0.7626196667945659
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,23711,175,1.06 [0.91-1.23],0.4844273984015723
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,23674,874,0.97 [0.91-1.04],0.4157430709520194
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21819,3940,1.02 [0.98-1.05],0.3093768727698227
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23455,514,1.08 [0.99-1.18],0.096089856484805
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23766,407,1.05 [0.95-1.16],0.3695138625538107
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23052,111,1.22 [1.01-1.47],0.0416611256508573
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22908,67,1.10 [0.86-1.40],0.439415025569559
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23497,1417,1.01 [0.96-1.07],0.6710327840856369
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,22928,108,1.04 [0.86-1.26],0.6960352046633568
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23445,1191,1.00 [0.94-1.06],0.980855785988816
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19580,3054,0.99 [0.95-1.02],0.503328713483794
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,18147,268,0.96 [0.85-1.08],0.4933789932942637
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23700,212,0.98 [0.85-1.12],0.7625783272459945
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23741,45,1.14 [0.85-1.53],0.3895991653046349
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22959,159,0.91 [0.77-1.06],0.235358467189175
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16707,181,0.88 [0.76-1.02],0.0912035826300364
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18304,425,1.01 [0.92-1.12],0.7642104166287351
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,18244,365,1.05 [0.95-1.17],0.358649165028792
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20038,2159,1.03 [0.98-1.07],0.2444245792968408
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18474,595,1.00 [0.92-1.09],0.9693709932789112
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18192,7985,1.00 [0.98-1.02],0.8545314226458097
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,23258,1178,0.98 [0.93-1.04],0.5966451885707491
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22987,46,1.12 [0.84-1.51],0.4302993453262761
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17495,1236,0.96 [0.91-1.02],0.2173163461193211
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22886,86,0.95 [0.77-1.18],0.6722494971317143
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,21758,3533,1.00 [0.96-1.03],0.9006167589334422
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,23744,42,1.26 [0.93-1.71],0.1372202882233676
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,16571,45,0.88 [0.65-1.19],0.4038115028331666
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,19854,1629,1.01 [0.96-1.06],0.6975815501625902
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18421,196,0.96 [0.84-1.11],0.6151617620263444
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16615,89,0.90 [0.73-1.11],0.3187157456970558
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22188,108,1.15 [0.95-1.39],0.1542717543251677
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16798,272,0.93 [0.82-1.05],0.2399065496123691
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23773,378,1.03 [0.93-1.14],0.6149919537845139
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23006,681,1.03 [0.96-1.11],0.4278034606661893
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23214,889,1.03 [0.96-1.10],0.3861735534357241
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18094,215,0.94 [0.82-1.08],0.40491481868454
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,18509,630,1.06 [0.98-1.15],0.1607758637126312
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23765,114,1.05 [0.87-1.27],0.592651087740397
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18297,72,1.14 [0.90-1.44],0.2936567491357182
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17961,1435,1.01 [0.96-1.06],0.784471845342472
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22515,261,0.99 [0.88-1.13],0.9315601275710372
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22377,123,1.05 [0.87-1.25],0.6304479154180527
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18408,1882,0.98 [0.93-1.02],0.3468142349697573
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21993,5467,0.99 [0.96-1.02],0.4196775919048314
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22893,180,1.10 [0.95-1.27],0.2232544792610506
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,23496,696,0.95 [0.88-1.03],0.2159840859412642
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18618,739,0.96 [0.90-1.04],0.3184880129330755
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22396,142,0.93 [0.79-1.10],0.4201672620349548
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23692,333,1.07 [0.96-1.19],0.2253459352929833
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18687,808,0.99 [0.93-1.07],0.8477918048568647
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23270,1190,0.99 [0.93-1.05],0.6609008917760566
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23119,178,1.06 [0.91-1.23],0.4555041536998295
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18161,1635,1.00 [0.95-1.05],0.9271779289400204
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19757,1878,0.99 [0.94-1.03],0.555068921173236
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22899,99,0.86 [0.70-1.05],0.1464717388571258
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23103,778,1.02 [0.95-1.09],0.6071592338532494
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16878,352,0.96 [0.86-1.07],0.4584964717580981
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23732,55,1.14 [0.87-1.49],0.3427856459986653
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17002,476,0.95 [0.87-1.04],0.2791462104367168
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22244,164,1.14 [0.98-1.33],0.0998139880422078
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23803,44,0.92 [0.68-1.24],0.5837168071567742
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22951,107,1.16 [0.95-1.40],0.1373025980008075
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Toxic colitis,22371,46,0.79 [0.58-1.06],0.1106033042759095
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18181,302,1.04 [0.93-1.17],0.4934953779862943
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22473,148,1.08 [0.92-1.27],0.3684817957986435
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22449,124,1.04 [0.87-1.24],0.6607509125254647
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,18591,366,0.99 [0.90-1.10],0.907724460495823
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16684,158,0.91 [0.77-1.07],0.2411803615337402
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,18484,259,1.03 [0.91-1.17],0.6186338147449291
PLA2G4A,Cytosolic phospholipase A2,Chapter XI Diseases of the digestive system,Volvulus,16600,74,0.93 [0.74-1.18],0.5538825605118134
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23740,332,0.95 [0.85-1.06],0.3502888915850094
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23502,69,1.13 [0.89-1.43],0.3342146522167766
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21819,98,1.00 [0.81-1.22],0.965801868791302
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23082,768,0.99 [0.92-1.06],0.7494166448571682
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22514,200,1.01 [0.88-1.16],0.9036070586328974
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22187,466,1.00 [0.92-1.10],0.9189194621339096
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23524,270,1.09 [0.96-1.23],0.1845990271744947
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23727,473,1.10 [1.00-1.21],0.0423320943004062
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23297,43,1.37 [1.01-1.86],0.0408303182589994
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22328,3188,1.00 [0.97-1.04],0.8613494264877679
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23368,405,1.01 [0.91-1.11],0.8527654042695524
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23258,295,1.00 [0.89-1.13],0.9620765464643992
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23356,1042,0.99 [0.93-1.05],0.724617579416494
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23806,29,1.13 [0.78-1.65],0.5064117488769888
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21744,23,1.72 [1.13-2.61],0.0105539773960906
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23019,56,1.05 [0.80-1.37],0.7350977649594933
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23519,265,1.08 [0.95-1.22],0.2404947295821217
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22201,480,0.98 [0.89-1.07],0.63340414979017
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21801,80,0.90 [0.72-1.13],0.3752593012112816
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23750,82,1.05 [0.84-1.31],0.6552751674324115
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22533,219,1.14 [0.99-1.30],0.0639926743892884
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23648,215,1.08 [0.95-1.24],0.2418175469881805
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23326,72,1.05 [0.83-1.33],0.7002335040809653
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21788,67,0.87 [0.68-1.11],0.2649516110319926
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23357,1636,1.00 [0.95-1.05],0.9825301247088116
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22242,521,0.98 [0.90-1.07],0.6643937419465884
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21804,83,0.92 [0.74-1.14],0.4369278653791386
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23727,294,1.11 [0.99-1.24],0.08228402284915
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23308,54,1.16 [0.88-1.52],0.2913252420240017
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23692,259,1.12 [0.99-1.26],0.0810957264825458
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23760,352,0.94 [0.85-1.05],0.2761919583829716
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21812,91,1.02 [0.83-1.26],0.8476807308485937
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21993,272,0.92 [0.81-1.04],0.1670532768072516
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23753,345,0.94 [0.85-1.05],0.2897654451726722
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21990,269,1.01 [0.90-1.14],0.835207019340892
PLA2G4A,Cytosolic phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23792,124,1.05 [0.88-1.26],0.5897106271726462
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20571,91,0.99 [0.81-1.22],0.9570978286840416
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21734,4782,1.04 [1.01-1.07],0.0087523644230394
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20320,3368,1.03 [1.00-1.07],0.0606641346659526
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20551,71,0.98 [0.77-1.24],0.8607379302341709
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20910,151,1.07 [0.91-1.26],0.4299519949342189
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20904,145,1.12 [0.95-1.33],0.1677674353331215
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23612,68,1.03 [0.81-1.31],0.8097653907441769
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20840,81,0.96 [0.77-1.20],0.7106669841495241
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17819,867,1.08 [1.00-1.15],0.0367037472376702
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23698,149,1.05 [0.89-1.24],0.5700369242147796
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21031,272,1.03 [0.92-1.17],0.5824261069621018
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20271,6262,1.04 [1.01-1.07],0.0026680680190683
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22748,90,0.85 [0.69-1.05],0.1327410619201856
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20647,167,0.84 [0.72-0.98],0.0279147745691127
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20909,429,1.04 [0.94-1.14],0.444851872714593
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22995,2236,1.02 [0.98-1.07],0.2920492203529884
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20844,364,0.99 [0.89-1.10],0.8199195935038444
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20534,54,1.42 [1.09-1.86],0.010180037484097
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20572,92,1.00 [0.81-1.23],0.9818172444388906
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23499,32,1.35 [0.95-1.92],0.093007690825362
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18414,1462,1.02 [0.97-1.08],0.3644306782647135
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17939,987,1.05 [0.98-1.12],0.1520081223385723
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23676,973,1.05 [0.98-1.12],0.1735789569051359
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16999,47,0.88 [0.66-1.18],0.4063470789678288
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),17032,80,1.03 [0.82-1.29],0.801411473193047
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20754,274,1.02 [0.91-1.16],0.696669312291678
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17578,626,1.03 [0.95-1.11],0.4737912582726737
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20802,43,1.19 [0.88-1.61],0.263823412049757
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21290,531,1.03 [0.95-1.13],0.4635055024097835
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21025,266,1.00 [0.88-1.13],0.9464872286894748
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17535,583,1.01 [0.93-1.10],0.7949570766811525
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20545,65,1.03 [0.80-1.32],0.8289931344977761
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20534,54,1.03 [0.78-1.34],0.851646238789172
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22751,93,1.06 [0.86-1.30],0.6097093712381888
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23526,868,0.97 [0.90-1.03],0.3032134015879508
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23066,408,0.93 [0.84-1.03],0.1594671056263389
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23732,288,1.11 [0.98-1.24],0.0922845124960701
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18832,1880,1.06 [1.01-1.11],0.0167403968769049
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,17004,52,0.88 [0.67-1.16],0.3660961033703881
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20563,83,1.18 [0.95-1.47],0.1411974139924758
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,17007,55,0.94 [0.72-1.23],0.6532794790024941
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16997,45,0.88 [0.65-1.18],0.388333756570377
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22845,187,0.98 [0.84-1.13],0.7501949192153471
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22820,162,0.96 [0.82-1.12],0.6111189901794258
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23781,85,1.12 [0.90-1.39],0.3076280929239846
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22284,1525,1.03 [0.98-1.09],0.2319272951350659
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20546,66,1.21 [0.94-1.54],0.1335381749846177
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16993,41,1.16 [0.84-1.58],0.3678421379190695
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21376,617,1.03 [0.95-1.11],0.4917052394589427
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18663,1711,1.03 [0.98-1.08],0.2267971532458334
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23524,57,1.33 [1.02-1.73],0.0333526808402558
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23798,63,1.15 [0.90-1.48],0.2630904075813762
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20561,81,0.96 [0.77-1.20],0.7290078709030072
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21463,983,1.07 [1.00-1.14],0.0454682928984145
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20576,96,0.86 [0.70-1.05],0.1378008053917739
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18158,1206,1.02 [0.96-1.08],0.4940136353473255
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22743,85,0.95 [0.77-1.18],0.6550098956023362
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20525,45,1.28 [0.95-1.73],0.1014030939284856
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20869,110,0.93 [0.77-1.13],0.4682751024202237
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20983,503,1.02 [0.93-1.12],0.6563917938890467
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23659,192,1.08 [0.94-1.25],0.2854183631022192
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21237,478,1.04 [0.95-1.14],0.3561767089617116
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23741,282,1.10 [0.97-1.24],0.1267928407731254
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23801,38,1.18 [0.85-1.63],0.3193445327158931
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20630,150,0.93 [0.79-1.10],0.3866885283099485
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19526,572,1.07 [0.99-1.17],0.1060937291775308
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20961,481,1.05 [0.96-1.15],0.2600350255054232
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20810,330,0.97 [0.87-1.08],0.5453284175414779
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16982,30,1.14 [0.79-1.64],0.4961219234986675
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19225,2273,1.05 [1.01-1.09],0.0269109247299814
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17405,453,0.96 [0.87-1.05],0.3668514841325035
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23628,161,1.03 [0.88-1.21],0.6920262313306962
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23743,47,1.04 [0.77-1.39],0.8116366364420304
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21830,44,1.08 [0.80-1.47],0.612657331045716
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,17017,65,1.14 [0.89-1.46],0.3102487863680427
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20846,87,1.04 [0.84-1.29],0.7169276898567187
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17248,296,1.11 [0.98-1.24],0.0903499780388006
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20760,280,1.11 [0.99-1.26],0.0771460944827565
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20976,217,1.14 [0.99-1.31],0.059220973260859
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20852,93,1.03 [0.83-1.26],0.8030730454203688
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18907,31,1.35 [0.94-1.92],0.1028586113072847
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23802,39,1.17 [0.85-1.62],0.3224170324150745
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21011,531,1.02 [0.94-1.12],0.6005740542389274
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23487,20,1.16 [0.74-1.82],0.517721850963018
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22744,2264,1.03 [0.99-1.07],0.1955671129783601
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20586,106,1.15 [0.95-1.40],0.1591260110252968
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21265,506,1.04 [0.95-1.14],0.3743784175500151
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22748,197,1.00 [0.87-1.15],0.9761259020940448
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20888,129,0.95 [0.80-1.13],0.5656132177240394
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22074,1315,1.02 [0.97-1.08],0.4273276460420389
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21580,821,1.02 [0.95-1.10],0.5294586209807257
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20523,43,1.14 [0.84-1.54],0.4091012188716807
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23506,39,1.53 [1.11-2.10],0.0086936601666762
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20596,116,1.27 [1.05-1.53],0.0119215173318797
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20503,23,0.78 [0.51-1.19],0.2489829893727741
PLA2G4A,Cytosolic phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),17012,60,0.93 [0.72-1.20],0.5585499060565868
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22802,1870,1.00 [0.95-1.05],0.9979451736884484
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23340,406,0.99 [0.89-1.09],0.7737756480299673
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23070,136,0.89 [0.75-1.06],0.1901772776011337
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22488,1556,0.95 [0.90-1.00],0.0326728430504931
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23563,86,0.86 [0.69-1.07],0.1828649856733141
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23533,362,0.97 [0.87-1.07],0.5150103181636524
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,20937,211,1.14 [0.99-1.31],0.0663971686270829
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,21037,105,0.98 [0.81-1.20],0.8653678472738611
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22532,3315,1.02 [0.98-1.05],0.359510432851428
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21442,5588,0.99 [0.96-1.02],0.4762234350216709
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23580,103,1.05 [0.86-1.28],0.630598415830729
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19424,207,0.92 [0.80-1.06],0.2477342853776107
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21039,373,1.10 [0.99-1.22],0.085174460313757
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21830,2613,1.02 [0.98-1.06],0.2889718738816031
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19449,232,0.95 [0.83-1.08],0.4145172139604389
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20804,78,0.91 [0.73-1.15],0.4414598742587607
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19325,108,0.88 [0.73-1.07],0.2135907899470416
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23804,61,1.17 [0.90-1.51],0.2376985535289959
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23809,58,0.84 [0.65-1.09],0.1882702392606259
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22981,2255,1.01 [0.97-1.05],0.6334038544151461
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21680,954,0.99 [0.93-1.06],0.7834088162076629
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23740,569,0.96 [0.88-1.04],0.3255718198865364
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19523,306,1.01 [0.90-1.13],0.91498115740367
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19494,277,0.99 [0.88-1.12],0.9160929467266696
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19447,230,0.97 [0.85-1.11],0.6894997153089383
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23799,49,1.06 [0.80-1.41],0.6877591791655937
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22263,1537,1.03 [0.98-1.08],0.3179374394758008
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21085,419,1.07 [0.97-1.18],0.1590926383607257
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23362,191,0.92 [0.79-1.06],0.2536944115653132
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23536,59,0.97 [0.75-1.26],0.8410414461218516
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19482,265,1.03 [0.91-1.16],0.643024603404798
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23513,2847,0.99 [0.95-1.03],0.5678925530140728
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20740,74,1.03 [0.82-1.30],0.8093221671183259
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21090,158,0.83 [0.71-0.98],0.0256337149698836
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23012,78,1.05 [0.84-1.32],0.669633124630102
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21023,297,0.98 [0.87-1.10],0.6702861443706336
PLA2G4A,Cytosolic phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23457,523,0.96 [0.88-1.04],0.3093090644841135
